Literature DB >> 24202570

Aluminium metabolism in chronic renat failure: Environmental influences and regional differences in Norway.

J Halse1, K P Nordal, E Dahl, Y Thomassen.   

Abstract

Many aspects of Al metabolism in chronic renal failure are poorly understood. A longitudinal study of serum Al concentrations in predialysis patients and healthy control subjects revealed very high values during the autumn of 1984 and 1985. Renal Al clearance was low during the autumnal spike in serum Al but increased substantially when the serum Al concentration declined. A second study confirmed that by using citric acid as a chelator, the gastrointestinal absorption of Al from Al(OH)3 may be considerably augmented as reflected by increases in both serum Al concentrations and renal Al clearance. The individual differences in Al absorption in this study were large.The first study suggests the existence of an unidentified environmental factor, possibly water borne, with profound effects on Al absorption and excretion. The citric acid/Al(OH)3 experiment suggests that the existence of such a factor is likely. The implications of these results are not known.A histomorphometric study of bone biopsies from 138 hemodialysis and 66 predialysis patients without clinical evidence of Al related disease, revealed Al deposits after staining with aurin tricarboxylic acid in 78% of the biopsies from the former and 24% of the latter patients. Serum Al concentrations did not differ between predialysis and hemodialysis patients with Al positive biopsies. Stratification of the hemodialysis patients, who came from all parts of Norway, revealed that patients living in regions with slightly Al contaminated drinking water (Al <30 μg/L) had lower serum Al concentrations than patients from regions with highly contaminated water (Al >100 μg/L). The prevalence of Al-positive biopsies was the same in both regions. Patients with Al-positive biopsies did not differ in serum Al level from those with Al-negative biopsies within the same region. Predialysis patients with Al-positive biopsies had significantly higher serum Al levels than predialysis patients with Al negative biopsies.Stainable Al deposits are commonly found in the bone of patients with chronic renal failure. Cross-sectionally obtained serum Al concentrations do not reflect the prevalence of stainable bone Al in renal patients but are related to the degree of Al contamination of water of the region.

Entities:  

Year:  1990        PMID: 24202570     DOI: 10.1007/BF01734053

Source DB:  PubMed          Journal:  Environ Geochem Health        ISSN: 0269-4042            Impact factor:   4.609


  11 in total

1.  Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.

Authors:  M R Wills; J Savory
Journal:  Lancet       Date:  1983-07-02       Impact factor: 79.321

2.  Aluminum transfer during hemodialysis.

Authors:  W D Kaehny; A C Alfrey; R E Holman; W J Shorr
Journal:  Kidney Int       Date:  1977-11       Impact factor: 10.612

3.  Seasonal variations in serum aluminum concentrations.

Authors:  K P Nordal; E Dahl; Y Thomassen; E K Brodwall; J Halse
Journal:  Pharmacol Toxicol       Date:  1988-02

4.  The effect of aluminium hydroxide orally on calcium, phosphorus and aluminium metabolism in normal subjects.

Authors:  J M Cam; V A Luck; J B Eastwood; H E de Wardener
Journal:  Clin Sci Mol Med       Date:  1976-10

5.  Low dose calcitriol versus placebo in patients with predialysis chronic renal failure.

Authors:  K P Nordal; E Dahl
Journal:  J Clin Endocrinol Metab       Date:  1988-11       Impact factor: 5.958

6.  Parathyroid hormone-mediated aluminum deposition and egress in the rat.

Authors:  G H Mayor; S M Sprague; M R Hourani; T V Sanchez
Journal:  Kidney Int       Date:  1980-01       Impact factor: 10.612

7.  Gastrointestinal absorption and urinary excretion of aluminium in patients with predialysis chronic renal failure.

Authors:  K P Nordal; E Dahl; K Sørhus; K J Berg; Y Thomassen; J Kofstad; J Halse
Journal:  Pharmacol Toxicol       Date:  1988-11

8.  Dietary citric acid enhances absorption of aluminum in antacids.

Authors:  P Slanina; W Frech; L G Ekström; L Lööf; S Slorach; A Cedergren
Journal:  Clin Chem       Date:  1986-03       Impact factor: 8.327

9.  Histomorphometric analysis of normal bone from the iliac crest of Norwegian subjects.

Authors:  E Dahl; K P Nordal; J Halse; A Attramadal
Journal:  Bone Miner       Date:  1988-03

10.  Serum-aluminum in nondialyzed chronic uremic patients before and during treatment with aluminum-containing phosphate-binding gels.

Authors:  M Brahm
Journal:  Clin Nephrol       Date:  1986-05       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.